Jaan Biotherapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $55K

  • Investors
  • 3

Jaan Biotherapeutics General Information

Description

Developer of novel therapies designed to treat cardiovascular diseases. The company's therapies activate the cardiac regeneration process in diseased hearts using proprietary technology and activate an endogenous cardiac muscle regeneration process that has been shut down in the adult human heart during evolution, enabling healthcare providers to cure their patients and improve their lives.

Contact Information

Website
www.jaanbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6331 Nancy Ridge Drive
  • Suite 204
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Jaan Biotherapeutics Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jaan Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-May-2021 $55K Completed Startup
3. Grant 26-Oct-2020 00000 Completed Startup
2. Angel (individual) 10-Mar-2016 Cancelled Startup
1. Accelerator/Incubator 10-Mar-2016 Completed Startup
To view Jaan Biotherapeutics’s complete valuation and funding history, request access »

Jaan Biotherapeutics Patents

Jaan Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4048398-A1 Compositions and methods for mitigation of ischemic reperfusion injury Pending 21-Oct-2019
US-20220307028-A1 Compositions and methods for mitigation of ischemic reperfusion injury Pending 21-Oct-2019 0000000000
EP-3484526-A1 Compositions and methods for treatment of cardiac diseases Pending 18-Jul-2016 0000000000
JP-2019521176-A Compositions and methods for the treatment of heart disease Pending 18-Jul-2016 0000000000
JP-2020186249-A Composition and method for treatment of cardiac disease Pending 18-Jul-2016 C12N15/113
To view Jaan Biotherapeutics’s complete patent history, request access »

Jaan Biotherapeutics Executive Team (2)

Name Title Board Seat Contact Info
Bhawanjit Brar Ph.D Co-Founder & Chief Executive Officer
Joseph Hansen JD Co-Founder & Chief Financial Officer
To view Jaan Biotherapeutics’s complete executive team members history, request access »

Jaan Biotherapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
CONNECT (Accelerator) Accelerator/Incubator 000 0000 000000 0
To view Jaan Biotherapeutics’s complete investors history, request access »